Products

What will AGI do for Adinazolam?

This classification denotes a benzodiazepine with the molecular formula C19H18ClN5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KN08449444, chemically known as 8-chloro-1-((dimethylamino)methyl)-6-phenyl-4h-s-triazolo(4,3-a)(1,4)benzodiazepine but generally known as adinazolam, which bears US NIH Compound Identifier 37632. Adinazolam most often comes in forms mesylate and monomethanesulfonate. European Medicines Agency schedules Adinazolam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05271MIG. The term ADINAZOLAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules adinazolam in its Anatomical Therapeutic Chemical (ATC) Classification. ADINAZOLAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule adinazolam under HS 29339940 and SITC 51577. As of Q4 2014, ADINAZOLAM remains the US FDA Preferred Term for this commodity. Adinazolam bears US NLM identifiers UMLS ID C0050844 and NCI Concept Code C76531. SMILES: Clc1cc2c(n3c(nnc3CN=C2c2ccccc2)CN(C)C)cc1.